Telling the truth about SME life today

IS Pharma goes for growth

Share on facebook
Share on twitter
Share on linkedin
Share on email

Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans.

IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology.

The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m.

IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.

Trending

Topic

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Stories

Trending

If you enjoyed this article,
why not join our newsletter?

We promise only quality content, tailored to suit what our readers like to see!